FRANCESCHINI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 10.637
EU - Europa 7.579
AS - Asia 1.719
OC - Oceania 17
SA - Sud America 16
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 19.998
Nazione #
US - Stati Uniti d'America 10.596
IT - Italia 3.440
CN - Cina 1.533
UA - Ucraina 1.441
DE - Germania 823
FI - Finlandia 396
IE - Irlanda 360
GB - Regno Unito 342
FR - Francia 266
PL - Polonia 129
SE - Svezia 100
BE - Belgio 84
RU - Federazione Russa 79
IN - India 63
CA - Canada 38
TR - Turchia 34
SG - Singapore 28
ES - Italia 19
RO - Romania 18
NL - Olanda 15
AU - Australia 14
EU - Europa 14
VN - Vietnam 14
MK - Macedonia 11
CH - Svizzera 10
GR - Grecia 9
IR - Iran 9
BR - Brasile 8
LU - Lussemburgo 8
EG - Egitto 6
SA - Arabia Saudita 6
JP - Giappone 5
UG - Uganda 5
AT - Austria 4
BG - Bulgaria 4
IL - Israele 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
CL - Cile 3
JO - Giordania 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SI - Slovenia 3
AM - Armenia 2
DK - Danimarca 2
HK - Hong Kong 2
ID - Indonesia 2
IQ - Iraq 2
LT - Lituania 2
PH - Filippine 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
KZ - Kazakistan 1
MS - Montserrat 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
VE - Venezuela 1
Totale 19.998
Città #
Fairfield 1.572
Woodbridge 1.143
Jacksonville 1.085
Houston 794
Ashburn 793
Cambridge 625
Seattle 588
Ann Arbor 587
Wilmington 563
Princeton 549
Chandler 477
Nanjing 350
Dublin 292
New York 277
Beijing 275
Helsinki 258
Milan 217
Brescia 157
Rome 132
Warsaw 124
Nanchang 121
San Diego 110
Des Moines 105
Hebei 105
Shenyang 99
Florence 84
Brussels 80
Changsha 78
Tianjin 73
Jinan 67
Jiaxing 63
London 62
Verona 55
Trieste 50
Hangzhou 47
Shanghai 45
Bergamo 44
Dearborn 42
San Francisco 41
Lancaster 38
Turin 35
Udine 34
Kunming 32
Ningbo 32
Padova 25
Toronto 25
Genova 24
Taizhou 23
Bologna 22
Haikou 22
Lanzhou 22
Zhengzhou 22
Kocaeli 21
Syracuse 21
Genoa 20
Menlo Park 20
Pisa 20
Torino 19
Nürnberg 18
Reggio Nell'emilia 18
Boardman 17
Mumbai 17
Redwood City 17
Guangzhou 15
Norwalk 15
Orange 15
Rozzano 15
Washington 15
Dong Ket 14
Monmouth Junction 14
Trento 14
Modena 13
Pune 13
San Mateo 13
Kilburn 12
Palermo 12
Bari 11
Dallas 11
Ferrara 11
Paris 11
Pordenone 11
Prescot 11
Rho 11
Cosenza 10
Desio 10
Falkenstein 10
Melbourne 10
Mountain View 10
Napoli 10
Pozzuolo Del Friuli 10
Sassari 10
Islington 9
Perugia 9
Taiyuan 9
Turriaco 9
Augusta 8
Chiswick 8
Fiumicino 8
Francenigo 8
Pescara 8
Totale 13.206
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 1.908
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.360
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 149
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 146
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 145
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 141
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 138
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 137
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 128
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 124
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 123
Antiphospholipid antibodies mediate autoimmunity against dying cells. 120
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 116
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 116
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 116
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 116
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 115
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 115
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 114
The clinico-serological spectrum of overlap myositis 114
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 113
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 112
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 111
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 111
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 110
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 109
Autoimmune polyendocrine Syndromes 107
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 107
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 107
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 106
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 104
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 103
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 102
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 102
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 101
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 101
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 100
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 100
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 100
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 100
Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: The positive experience of a national multicentre study 99
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 98
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 96
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 96
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 96
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 96
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 94
Incidence of antiperinuclear factor in patients with psoriatic arthritis. 94
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 94
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 93
Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. 92
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 92
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 92
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 92
Antiperinuclear factor in psoriatic arthropathy 90
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 90
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 89
Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference 87
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 87
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 87
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 86
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 86
Pathogenetic associations of maternal anti-Ro/SSA antibodies. 86
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 85
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 84
Determination of antibodies to extractable nuclear antigens by commercial kits: a multicenter study 84
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 83
Anti-Ro/SSA and La/SSB antibodies 83
Serologic profile and mortality rates of scleroderma renal crisis in Italy 82
Myositis autoantibodies and clinical phenotypes 82
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 81
Switching from Intravenous to Subcutaneous Formulation of Abatacept: A Single-center Italian Experience on Efficacy and Safety 81
The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus 81
Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients 81
Update on Antiphospholipid Syndrome: Ten Topics in 2017 81
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 81
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 79
Cardiological features in idiopathic inflammatory myopathies. 79
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 78
Incidence of antiperinuclear factor in sera of patients with psoriatic arthritis 77
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 77
Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al 77
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 77
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 76
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 76
Echocardiographic Evaluation of Asymptomatic Patients Affected by Rheumatoid Arthritis 76
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 76
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 75
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 75
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 75
Retention of a bile acid analogue in the enterohepatic circulation (EHC) in primary biliary cirrhosis (PBC): comparison with normal controls and effect of bile acid treatment. 74
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience. 74
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 73
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 73
Elastic properties of the ascending aorta in patients with rheumatoid arthritis. 72
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors 72
Transient neonatal bradycardia without heart block associated with anti-Ro antibodies 72
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 72
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 70
Antinuclear antibodies in psoriatic arthritis and its subgroups 70
Totale 12.623
Categoria #
all - tutte 89.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.356 0 0 0 0 0 0 0 266 66 221 397 406
2019/20205.026 782 162 187 528 285 510 414 538 384 748 166 322
2020/20214.009 94 438 162 444 242 467 156 446 466 472 395 227
2021/20223.010 185 401 140 176 164 200 201 234 193 296 272 548
2022/20232.311 341 38 51 99 194 564 53 232 394 64 154 127
2023/20241.594 157 89 237 252 141 458 134 126 0 0 0 0
Totale 20.446